CoinXview PortfolioApp
EN

Nasdaq approves Canary's staked Injective (INJ) ETF listing.

· Source: The Defiant

Nasdaq approved the listing of Canary's Staked Injective ETF, which will stake at least 90% of its INJ holdings and charge a 1.10% annual sponsor fee.

The original site blocks automated reading and no other outlet has covered this yet, so this is only a short summary based on The Defiant's own description. Read the full story at the source.

Positive Price impact: 65/100

INJ price around the news

Dashed line: news time ($7.86) Now: $6.83 -12.99%

Related coins

Read the original on The Defiant ↗

Get notified of important news

News with a price impact of 75/100 or more, and news from 60/100 about coins in this device's watchlist (☆). At most 6 per day; tapping opens the summary on our site.

Summary and rating written automatically by the AI of CoinXview from the original article; it may be incomplete or wrong — read the original for details. Not investment advice.

More news about INJ

All news →

All sections